News
/
/
/
Congratulations to Shandong Viwit Pharmaceutic Industry Co., Ltd.

News classification

Check category

Popular information

Congratulations to Shandong Viwit Pharmaceutic Industry Co., Ltd.

  • Categories:In 2016
  • Author:
  • Origin:
  • Time of issue:2020-01-24 01:10

(Summary description)In October 2016, Shandong Viwit accepted the 5-day GMP on-site review of the Atazanavir Sulfate API by the Ministry of Health of Mexico (COFEPRIS), and again with "zero defect" results Successfully passed the audit.

Following the first COFEPRIS audit in 2014, Viwit successfully passed the on-site inspection with excellent results. Due to the increasing global GMP requirements, this audit is more stringent than in the past, but Viwit has always adhered to the concept of cGMP norms and continued to improve its quality management. The production environment and quality system have left a good impression on the COPRIPRIS auditors.

The GMP review by COFEPRIS in Mexico strengthened Viwit's belief in healthy products. Viwit will continue to adhere to the GMP standard, strictly control each link, and provide more safe and high quality API products.

Congratulations to Shandong Viwit Pharmaceutic Industry Co., Ltd.

(Summary description)In October 2016, Shandong Viwit accepted the 5-day GMP on-site review of the Atazanavir Sulfate API by the Ministry of Health of Mexico (COFEPRIS), and again with "zero defect" results Successfully passed the audit.

Following the first COFEPRIS audit in 2014, Viwit successfully passed the on-site inspection with excellent results. Due to the increasing global GMP requirements, this audit is more stringent than in the past, but Viwit has always adhered to the concept of cGMP norms and continued to improve its quality management. The production environment and quality system have left a good impression on the COPRIPRIS auditors.

The GMP review by COFEPRIS in Mexico strengthened Viwit's belief in healthy products. Viwit will continue to adhere to the GMP standard, strictly control each link, and provide more safe and high quality API products.

  • Categories:In 2016
  • Author:
  • Origin:
  • Time of issue:2020-01-24 01:10
  • Views:
Information

In October 2016, Shandong Viwit accepted the 5-day GMP on-site review of the Atazanavir Sulfate API by the Ministry of Health of Mexico (COFEPRIS), and again with "zero defect" results Successfully passed the audit.

Following the first COFEPRIS audit in 2014, Viwit successfully passed the on-site inspection with excellent results. Due to the increasing global GMP requirements, this audit is more stringent than in the past, but Viwit has always adhered to the concept of cGMP norms and continued to improve its quality management. The production environment and quality system have left a good impression on the COPRIPRIS auditors.

The GMP review by COFEPRIS in Mexico strengthened Viwit's belief in healthy products. Viwit will continue to adhere to the GMP standard, strictly control each link, and provide more safe and high quality API products.

Scan the QR code to read on your phone

search
Confirm
Close

VIWIT  Shanghai  ICP  12014533-1